| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal protein binding | ESPN ANK3 KIF1A MARK3 DISC1 PPP1R9A SPTBN1 TRIOBP EPS8L1 CEP350 CCDC88C TTBK2 ALMS1 SSH1 ABRAXAS1 FHOD1 SYNE2 VASH2 KCNQ2 ARHGEF2 UTRN FRMD5 EPB41L2 HTT | 5.86e-06 | 1099 | 158 | 24 | GO:0008092 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | DAB2IP RASA1 RAPGEF4 ARHGAP17 ALS2 EPS8L1 RGS3 DENND4C CCDC88C RIN2 RIMS1 HERC2 ARHGEF2 HERC1 RASAL2 | 1.26e-05 | 507 | 158 | 15 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | DAB2IP RASA1 RAPGEF4 ARHGAP17 ALS2 EPS8L1 RGS3 DENND4C CCDC88C RIN2 RIMS1 HERC2 ARHGEF2 HERC1 RASAL2 | 1.26e-05 | 507 | 158 | 15 | GO:0030695 |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | RAPGEF4 ALS2 EPS8L1 DENND4C CCDC88C RIN2 HERC2 ARHGEF2 HERC1 | 9.58e-05 | 231 | 158 | 9 | GO:0005085 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | PCDHB13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDH12 CDH8 | 2.10e-08 | 187 | 157 | 12 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | PCDHB13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDH12 CDH8 | 5.17e-06 | 313 | 157 | 12 | GO:0098742 |
| GeneOntologyBiologicalProcess | telencephalon development | DAB2IP DISC1 TSC1 ATAT1 WDR37 SYNE2 KCNQ2 NUMB TBR1 HERC1 HTT PCNT | 9.38e-06 | 332 | 157 | 12 | GO:0021537 |
| GeneOntologyBiologicalProcess | regulation of organelle organization | ESPN RASA1 SEPTIN9 PPP1R9A SPTBN1 TRIOBP ARHGAP17 MARCHF7 TSC1 ATAT1 SYT7 MAP3K4 CCDC88C TTBK2 VPS13D ALMS1 SSH1 SLF2 HECW2 FHOD1 SYNE2 BUB1 RIMS1 HAX1 ARHGEF2 HTT | 9.71e-06 | 1342 | 157 | 26 | GO:0033043 |
| GeneOntologyBiologicalProcess | forebrain development | DAB2IP KIF1A DISC1 TSC1 ATAT1 WDR37 TTBK2 SYNE2 KCNQ2 NUMB TBR1 HERC1 HTT PCNT | 2.33e-05 | 489 | 157 | 14 | GO:0030900 |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | DAB2IP ESPN RASA1 SEPTIN9 PPP1R9A SPTBN1 TRIOBP MARCHF7 TSC1 EPS8L1 ATAT1 TTBK2 ALMS1 SSH1 SLF2 FHOD1 SYNE2 LRP4 NUMB RIMS1 HAX1 ARHGEF2 HTT | 3.46e-05 | 1189 | 157 | 23 | GO:0044087 |
| GeneOntologyBiologicalProcess | regulation of cytoskeleton organization | ESPN RASA1 PPP1R9A SPTBN1 TRIOBP ARHGAP17 TSC1 ATAT1 CCDC88C TTBK2 ALMS1 SSH1 FHOD1 HAX1 ARHGEF2 | 3.76e-05 | 579 | 157 | 15 | GO:0051493 |
| GeneOntologyBiologicalProcess | synapse organization | DAB2IP CACNA1S ANK3 KIF1A DISC1 PPP1R9A PCDHB13 RAPGEF4 ALS2 TSC1 CNKSR2 SHISA7 SSH1 LRP4 NUMB CDH8 | 7.05e-05 | 685 | 157 | 16 | GO:0050808 |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | DAB2IP ESPN KIF1A DISC1 SEPTIN9 PPP1R9A RAPGEF4 MARCHF7 TSC1 EPS8L1 TTBK2 RNF6 HECW2 SYNE2 LRP4 NUMB TBR1 HTT | 8.11e-05 | 846 | 157 | 18 | GO:0120035 |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | DAB2IP ESPN KIF1A DISC1 SEPTIN9 PPP1R9A RAPGEF4 MARCHF7 TSC1 EPS8L1 TTBK2 RNF6 HECW2 SYNE2 LRP4 NUMB TBR1 HTT | 1.04e-04 | 863 | 157 | 18 | GO:0031344 |
| GeneOntologyBiologicalProcess | neuron development | DAB2IP ANK3 KIF1A DISC1 PPP1R9A LAMA1 RAPGEF4 TRIOBP ALS2 TSC1 PCDH12 ATAT1 ECE1 ALMS1 RNF6 HECW2 VASH2 LRP4 KCNQ2 NUMB RIMS1 TBR1 HERC1 TBC1D23 HTT | 1.15e-04 | 1463 | 157 | 25 | GO:0048666 |
| GeneOntologyBiologicalProcess | positive regulation of non-motile cilium assembly | 1.17e-04 | 13 | 157 | 3 | GO:1902857 | |
| GeneOntologyBiologicalProcess | negative regulation of cytoskeleton organization | 1.23e-04 | 194 | 157 | 8 | GO:0051494 | |
| GeneOntologyBiologicalProcess | regulation of supramolecular fiber organization | RASA1 PPP1R9A SPTBN1 TRIOBP TSC1 CCDC88C TTBK2 ALMS1 SSH1 FHOD1 HAX1 ARHGEF2 | 1.37e-04 | 438 | 157 | 12 | GO:1902903 |
| GeneOntologyBiologicalProcess | cell morphogenesis | DAB2IP ANK3 RASA1 KIF1A DISC1 PPP1R9A LAMA1 TRIOBP ALS2 ECE1 CCDC88C RNF6 SSH1 HECW2 LRP4 NUMB RIMS1 TBR1 ARHGEF2 CDH8 EPB41L2 | 2.91e-04 | 1194 | 157 | 21 | GO:0000902 |
| GeneOntologyBiologicalProcess | cilium organization | ABCC4 DISC1 SEPTIN9 MARCHF7 ATAT1 CEP350 CCDC88C TTBK2 ALMS1 SYNE2 HTT PCNT | 2.95e-04 | 476 | 157 | 12 | GO:0044782 |
| GeneOntologyBiologicalProcess | non-motile cilium assembly | 3.23e-04 | 78 | 157 | 5 | GO:1905515 | |
| GeneOntologyBiologicalProcess | regulation of non-motile cilium assembly | 3.25e-04 | 18 | 157 | 3 | GO:1902855 | |
| GeneOntologyCellularComponent | postsynaptic density | ANK3 DISC1 PPP1R9A SPTBN1 RAPGEF4 ALS2 TSC1 CNKSR2 SHISA7 LRP4 NUMB RIMS1 ARHGEF2 DAGLA | 1.02e-05 | 451 | 160 | 14 | GO:0014069 |
| GeneOntologyCellularComponent | neuron to neuron synapse | ANK3 DISC1 PPP1R9A SPTBN1 RAPGEF4 ALS2 TSC1 CNKSR2 SYT7 SHISA7 LRP4 NUMB RIMS1 ARHGEF2 DAGLA | 1.24e-05 | 523 | 160 | 15 | GO:0098984 |
| GeneOntologyCellularComponent | asymmetric synapse | ANK3 DISC1 PPP1R9A SPTBN1 RAPGEF4 ALS2 TSC1 CNKSR2 SHISA7 LRP4 NUMB RIMS1 ARHGEF2 DAGLA | 1.90e-05 | 477 | 160 | 14 | GO:0032279 |
| GeneOntologyCellularComponent | postsynaptic specialization | ANK3 DISC1 PPP1R9A SPTBN1 RAPGEF4 ALS2 TSC1 CNKSR2 SHISA7 LRP4 NUMB RIMS1 ARHGEF2 DAGLA | 3.39e-05 | 503 | 160 | 14 | GO:0099572 |
| GeneOntologyCellularComponent | postsynapse | CACNA1S ANK3 KIF1A DISC1 PPP1R9A SPTBN1 PCDHB13 RAPGEF4 DDN ALS2 TSC1 CNKSR2 SHISA7 LRP4 NUMB RIMS1 ARHGEF2 UTRN DAGLA HTT | 1.04e-04 | 1018 | 160 | 20 | GO:0098794 |
| GeneOntologyCellularComponent | cell leading edge | RASA1 PPP1R9A SPTBN1 DDN ALS2 TSC1 EPS8L1 SHISA7 SSH1 SYNE2 HAX1 ARHGEF2 DAGLA | 1.29e-04 | 500 | 160 | 13 | GO:0031252 |
| GeneOntologyCellularComponent | axon | DAB2IP MAF1 ANK3 KIF1A DISC1 PPP1R9A SPTBN1 RAPGEF4 ALS2 TSC1 ATAT1 SYT7 RNF6 SSH1 KCNQ2 DAGLA CDH8 HTT | 1.67e-04 | 891 | 160 | 18 | GO:0030424 |
| GeneOntologyCellularComponent | dendrite | DAB2IP MAF1 CACNA1S ANK3 KIF1A MARK3 PPP1R9A RAPGEF4 DDN ALS2 SYT7 SHISA7 LRP4 NUMB ARHGEF2 DAGLA HTT | 3.21e-04 | 858 | 160 | 17 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | DAB2IP MAF1 CACNA1S ANK3 KIF1A MARK3 PPP1R9A RAPGEF4 DDN ALS2 SYT7 SHISA7 LRP4 NUMB ARHGEF2 DAGLA HTT | 3.29e-04 | 860 | 160 | 17 | GO:0097447 |
| GeneOntologyCellularComponent | dendritic spine membrane | 3.30e-04 | 18 | 160 | 3 | GO:0032591 | |
| GeneOntologyCellularComponent | centriole | 3.67e-04 | 172 | 160 | 7 | GO:0005814 | |
| GeneOntologyCellularComponent | dendritic spine | 5.66e-04 | 242 | 160 | 8 | GO:0043197 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum | 5.80e-04 | 88 | 160 | 5 | GO:0016529 | |
| GeneOntologyCellularComponent | neuron spine | 6.48e-04 | 247 | 160 | 8 | GO:0044309 | |
| GeneOntologyCellularComponent | somatodendritic compartment | DAB2IP VGF MAF1 CACNA1S ANK3 KIF1A MARK3 PPP1R9A RAPGEF4 DDN ALS2 CNKSR2 SYT7 SHISA7 LRP4 NUMB CCR1 ARHGEF2 DAGLA HTT | 1.15e-03 | 1228 | 160 | 20 | GO:0036477 |
| GeneOntologyCellularComponent | leading edge membrane | 1.19e-03 | 210 | 160 | 7 | GO:0031256 | |
| GeneOntologyCellularComponent | anchoring junction | ESPN ANK3 LAMA1 TRIOBP PCDHA12 ARHGAP17 PCDH12 ATAT1 CCDC88C FHOD1 SYNE2 NUMB ARHGEF2 CDH8 FRMD5 EPB41L2 PDZD2 | 1.34e-03 | 976 | 160 | 17 | GO:0070161 |
| GeneOntologyCellularComponent | synaptic membrane | ANK3 PCDHB13 DDN CNKSR2 SYT7 SHISA7 LRP4 RIMS1 UTRN DAGLA CDH8 HTT | 1.81e-03 | 583 | 160 | 12 | GO:0097060 |
| GeneOntologyCellularComponent | sarcoplasm | 1.85e-03 | 114 | 160 | 5 | GO:0016528 | |
| GeneOntologyCellularComponent | spectrin-associated cytoskeleton | 2.02e-03 | 9 | 160 | 2 | GO:0014731 | |
| GeneOntologyCellularComponent | spectrin | 2.02e-03 | 9 | 160 | 2 | GO:0008091 | |
| Domain | Cadherin_2 | PCDHB13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDH12 | 5.47e-12 | 65 | 155 | 11 | PF08266 |
| Domain | Cadherin_N | PCDHB13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDH12 | 5.47e-12 | 65 | 155 | 11 | IPR013164 |
| Domain | Cadherin_tail | PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 | 1.51e-11 | 37 | 155 | 9 | PF15974 |
| Domain | Cadherin_CBD | PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 | 1.51e-11 | 37 | 155 | 9 | IPR031904 |
| Domain | Cadherin_CS | PCDHB13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDH12 CDH8 | 1.09e-10 | 109 | 155 | 12 | IPR020894 |
| Domain | CADHERIN_1 | PCDHB13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDH12 CDH8 | 1.67e-10 | 113 | 155 | 12 | PS00232 |
| Domain | Cadherin | PCDHB13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDH12 CDH8 | 1.67e-10 | 113 | 155 | 12 | PF00028 |
| Domain | CADHERIN_2 | PCDHB13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDH12 CDH8 | 1.85e-10 | 114 | 155 | 12 | PS50268 |
| Domain | - | PCDHB13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDH12 CDH8 | 1.85e-10 | 114 | 155 | 12 | 2.60.40.60 |
| Domain | CA | PCDHB13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDH12 CDH8 | 2.05e-10 | 115 | 155 | 12 | SM00112 |
| Domain | Cadherin-like | PCDHB13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDH12 CDH8 | 2.27e-10 | 116 | 155 | 12 | IPR015919 |
| Domain | Cadherin | PCDHB13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDH12 CDH8 | 2.78e-10 | 118 | 155 | 12 | IPR002126 |
| Domain | PH_dom-like | DAB2IP RASA1 KIF1A SPTBN1 FRMPD1 TRIOBP ALS2 CNKSR2 EPS8L1 RGS3 OSBPL6 NUMB ARHGEF2 FRMD5 EPB41L2 RASAL2 | 5.33e-07 | 426 | 155 | 16 | IPR011993 |
| Domain | - | DAB2IP RASA1 KIF1A SPTBN1 TRIOBP ALS2 CNKSR2 RGS3 OSBPL6 NUMB ARHGEF2 FRMD5 EPB41L2 RASAL2 | 4.92e-06 | 391 | 155 | 14 | 2.30.29.30 |
| Domain | C2_dom | 6.87e-05 | 164 | 155 | 8 | IPR000008 | |
| Domain | C2 | 1.12e-04 | 131 | 155 | 7 | PF00168 | |
| Domain | PH | DAB2IP RASA1 KIF1A SPTBN1 TRIOBP ALS2 CNKSR2 OSBPL6 ARHGEF2 RASAL2 | 1.12e-04 | 278 | 155 | 10 | SM00233 |
| Domain | PH_DOMAIN | DAB2IP RASA1 KIF1A SPTBN1 TRIOBP ALS2 CNKSR2 OSBPL6 ARHGEF2 RASAL2 | 1.15e-04 | 279 | 155 | 10 | PS50003 |
| Domain | PH_domain | DAB2IP RASA1 KIF1A SPTBN1 TRIOBP ALS2 CNKSR2 OSBPL6 ARHGEF2 RASAL2 | 1.19e-04 | 280 | 155 | 10 | IPR001849 |
| Domain | C2 | 1.48e-04 | 137 | 155 | 7 | SM00239 | |
| Domain | C2 | 1.85e-04 | 142 | 155 | 7 | PS50004 | |
| Domain | RasGAP | 1.91e-04 | 14 | 155 | 3 | SM00323 | |
| Domain | RasGAP_CS | 1.91e-04 | 14 | 155 | 3 | IPR023152 | |
| Domain | DUF3498 | 2.04e-04 | 3 | 155 | 2 | IPR021887 | |
| Domain | DUF3498 | 2.04e-04 | 3 | 155 | 2 | PF12004 | |
| Domain | RasGAP | 2.37e-04 | 15 | 155 | 3 | PF00616 | |
| Domain | RAS_GTPASE_ACTIV_1 | 2.37e-04 | 15 | 155 | 3 | PS00509 | |
| Domain | RAS_GTPASE_ACTIV_2 | 2.37e-04 | 15 | 155 | 3 | PS50018 | |
| Domain | - | 2.38e-04 | 148 | 155 | 7 | 2.60.40.150 | |
| Domain | - | 2.90e-04 | 16 | 155 | 3 | 1.10.506.10 | |
| Domain | RasGAP_dom | 4.17e-04 | 18 | 155 | 3 | IPR001936 | |
| Domain | RCC1 | 5.76e-04 | 20 | 155 | 3 | PF00415 | |
| Domain | RCC1_1 | 6.68e-04 | 21 | 155 | 3 | PS00625 | |
| Domain | RCC1_2 | 6.68e-04 | 21 | 155 | 3 | PS00626 | |
| Domain | RCC1_3 | 6.68e-04 | 21 | 155 | 3 | PS50012 | |
| Domain | - | 7.69e-04 | 22 | 155 | 3 | 2.130.10.30 | |
| Domain | Reg_chr_condens | 7.69e-04 | 22 | 155 | 3 | IPR000408 | |
| Domain | SEA | 7.69e-04 | 22 | 155 | 3 | PF01390 | |
| Domain | Spectrin | 8.79e-04 | 23 | 155 | 3 | PF00435 | |
| Domain | ACTININ_2 | 8.79e-04 | 23 | 155 | 3 | PS00020 | |
| Domain | ACTININ_1 | 8.79e-04 | 23 | 155 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 8.79e-04 | 23 | 155 | 3 | IPR001589 | |
| Domain | SEA | 8.79e-04 | 23 | 155 | 3 | PS50024 | |
| Domain | SEA_dom | 8.79e-04 | 23 | 155 | 3 | IPR000082 | |
| Domain | RCC1/BLIP-II | 8.79e-04 | 23 | 155 | 3 | IPR009091 | |
| Domain | PDZ | 1.16e-03 | 141 | 155 | 6 | PF00595 | |
| Domain | HECT | 1.42e-03 | 27 | 155 | 3 | PF00632 | |
| Domain | HECTc | 1.42e-03 | 27 | 155 | 3 | SM00119 | |
| Domain | HECT_dom | 1.42e-03 | 27 | 155 | 3 | IPR000569 | |
| Domain | HECT | 1.42e-03 | 27 | 155 | 3 | PS50237 | |
| Domain | PDZ | 1.48e-03 | 148 | 155 | 6 | SM00228 | |
| Domain | - | 1.59e-03 | 150 | 155 | 6 | 2.30.42.10 | |
| Domain | PDZ | 1.64e-03 | 151 | 155 | 6 | PS50106 | |
| Domain | PDZ | 1.70e-03 | 152 | 155 | 6 | IPR001478 | |
| Domain | Spectrin_repeat | 1.75e-03 | 29 | 155 | 3 | IPR002017 | |
| Domain | UBA | 1.93e-03 | 30 | 155 | 3 | SM00165 | |
| Domain | SPEC | 2.33e-03 | 32 | 155 | 3 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 2.33e-03 | 32 | 155 | 3 | IPR018159 | |
| Domain | FERM_N | 2.55e-03 | 33 | 155 | 3 | IPR018979 | |
| Domain | FERM_N | 2.55e-03 | 33 | 155 | 3 | PF09379 | |
| Domain | VPS9 | 2.95e-03 | 10 | 155 | 2 | PS51205 | |
| Domain | VPS9 | 2.95e-03 | 10 | 155 | 2 | PF02204 | |
| Domain | VPS9 | 2.95e-03 | 10 | 155 | 2 | IPR003123 | |
| Domain | PH | 3.05e-03 | 229 | 155 | 7 | PF00169 | |
| Pubmed | PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 | 3.80e-18 | 15 | 161 | 9 | 15640798 | |
| Pubmed | PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 | 1.83e-17 | 17 | 161 | 9 | 29911975 | |
| Pubmed | CNR/Pcdhalpha family in subplate neurons, and developing cortical connectivity. | PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 | 3.65e-17 | 18 | 161 | 9 | 15570159 |
| Pubmed | Genomic organization of the family of CNR cadherin genes in mice and humans. | PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 | 3.65e-17 | 18 | 161 | 9 | 10662547 |
| Pubmed | PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 | 9.59e-16 | 24 | 161 | 9 | 24698270 | |
| Pubmed | Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha. | PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 | 4.99e-15 | 28 | 161 | 9 | 15347688 |
| Pubmed | Diversity revealed by a novel family of cadherins expressed in neurons at a synaptic complex. | 1.30e-14 | 11 | 161 | 7 | 9655502 | |
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | PCDHB13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDH12 | 3.51e-14 | 72 | 161 | 11 | 10380929 |
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | PCDHB13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDH12 | 4.81e-14 | 74 | 161 | 11 | 10817752 |
| Pubmed | PCDHB13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDH12 | 7.60e-14 | 77 | 161 | 11 | 10835267 | |
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | PCDHB13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDH12 | 1.18e-13 | 80 | 161 | 11 | 10716726 |
| Pubmed | Clustered gamma-protocadherins regulate cortical interneuron programmed cell death. | PCDHB13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 | 1.22e-13 | 57 | 161 | 10 | 32633719 |
| Pubmed | CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons. | PCDHB13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 | 1.47e-13 | 58 | 161 | 10 | 30377227 |
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | PCDHB13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 | 7.87e-13 | 68 | 161 | 10 | 11230163 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | MARK3 EXPH5 SPTBN1 ARHGAP17 SIK1 ALS2 ATAT1 DENND4C NSD3 CEP350 CCDC88C VPS13D ALMS1 SLF2 SYNE2 OSBPL6 KMT2A NUMB ARHGEF2 PC SRRM2 UTRN EPB41L2 RASAL2 | 2.03e-12 | 861 | 161 | 24 | 36931259 |
| Pubmed | Proteins of the CNR family are multiple receptors for Reelin. | 8.09e-12 | 12 | 161 | 6 | 10612399 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ESPN PITPNM2 ABCC4 TP53INP1 ANK3 RASA1 KIF1A MARK3 SEPTIN9 PPP1R9A FRMPD1 TRIOBP SRPK2 ATAT1 WDR37 TRRAP ANKRD44 FOXP4 TLE3 RIN2 NUMB RIMS1 UTRN SAP130 DAGLA HTT PCNT PDZD2 FAM149A | 5.18e-11 | 1489 | 161 | 29 | 28611215 |
| Pubmed | The DNA sequence and comparative analysis of human chromosome 5. | PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 | 7.54e-11 | 75 | 161 | 9 | 15372022 |
| Pubmed | DAB2IP VGF ANK3 PPP1R9A SPTBN1 UBR4 RAPGEF4 DDN TRIOBP SRPK2 TSC1 CNKSR2 SHISA7 CCDC88C SSH1 SYNE2 RIMS1 HERC2 ARHGEF2 EPB41L2 RASAL2 PCNT | 7.84e-10 | 963 | 161 | 22 | 28671696 | |
| Pubmed | DAB2IP MARK3 SEPTIN9 PPP1R9A FRMPD1 DDN ALS2 TSC1 CNKSR2 MAP3K4 IGDCC4 TLE3 SRRM2 PCNT PDZD2 | 8.57e-10 | 407 | 161 | 15 | 12693553 | |
| Pubmed | PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 TBC1D23 WDR49 | 1.86e-09 | 193 | 161 | 11 | 22589738 | |
| Pubmed | PITPNM2 ANK3 MARK3 SEPTIN9 PPP1R9A SPTBN1 RAPGEF4 KIAA1549 SRPK2 TSC1 CNKSR2 WDR37 HECW2 CRACDL OSBPL6 KMT2A OGDHL KCNQ2 RIMS1 HAX1 ARHGEF2 PC UTRN DAGLA EPB41L2 RASAL2 | 2.51e-09 | 1431 | 161 | 26 | 37142655 | |
| Pubmed | DAB2IP ANK3 PPP1R9A SPTBN1 TRIOBP KIAA1549 TSC1 NSD3 CEP350 SSH1 TLE3 SYNE2 NUMB POC5 HAX1 HERC2 ARHGEF2 HERC1 PC SRRM2 UTRN PCNT | 3.75e-09 | 1049 | 161 | 22 | 27880917 | |
| Pubmed | A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220. | PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 | 4.88e-09 | 119 | 161 | 9 | 28625976 |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | DAB2IP PITPNM2 ANK3 PPP1R9A SPTBN1 RAPGEF4 DDN CNKSR2 SHISA7 RIMS1 EPB41L2 RASAL2 | 8.75e-09 | 281 | 161 | 12 | 28706196 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | DAB2IP PITPNM2 UBR4 ARHGAP17 MCM5 REV3L ECE1 TRRAP NSD3 ORC1 CCDC88C SSH1 LRP4 OGDHL KCNQ2 HERC2 ARHGEF2 HERC1 PC HTT PCNT MYBL2 | 9.58e-09 | 1105 | 161 | 22 | 35748872 |
| Pubmed | ANK3 KIF1A RSL1D1 SPTBN1 UBR4 RAPGEF4 TRIOBP NUP43 SRPK2 REV3L ZKSCAN5 CEP350 UBE4A HEATR6 SLF2 LRP4 KCNQ2 HERC2 TBC1D23 PC UTRN RASAL2 PCNT | 3.04e-08 | 1285 | 161 | 23 | 35914814 | |
| Pubmed | TMEM74B PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA3 PCDHA2 ORC1 RIMS1 CNTFR | 4.97e-08 | 329 | 161 | 12 | 17474147 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | CACNA1S ANK3 DISC1 UBR4 DDN CNKSR2 APOBR ZKSCAN5 LARP4B BUB1 NUMB SAP130 PCNT | 1.20e-07 | 430 | 161 | 13 | 35044719 |
| Pubmed | KIF1A RSL1D1 ZC3H13 SPTBN1 UBR4 MCM5 TRRAP LARP4B SYNE2 KMT2A HERC2 SRRM2 UTRN EPB41L2 PCNT | 4.29e-07 | 653 | 161 | 15 | 22586326 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | ANK3 RSL1D1 EXPH5 CWC15 SEPTIN9 SPTBN1 RAPGEF4 TSC1 TRRAP MAP3K4 VPS13D KMT2A HERC1 | 6.20e-07 | 497 | 161 | 13 | 36774506 |
| Pubmed | ABCC4 COL12A1 ANK3 EXPH5 CWC15 SPTBN1 ALS2 CNKSR2 REV3L ATAT1 ECE1 RGS3 ORC1 RNF6 SSH1 TLE3 BUB1 OGDHL SAP130 PCNT FCMR | 6.28e-07 | 1293 | 161 | 21 | 15342556 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | RSL1D1 SEPTIN9 ZC3H13 SPTBN1 ZNF507 TRRAP SSH1 TLE3 FHOD1 MSL3 KMT2A RIMS1 ARHGEF2 SRRM2 EPB41L2 MYBL2 | 7.01e-07 | 774 | 161 | 16 | 15302935 |
| Pubmed | 1.50e-06 | 76 | 161 | 6 | 27542412 | ||
| Pubmed | 2.35e-06 | 46 | 161 | 5 | 37207277 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | TTF2 SEPTIN9 ZNF507 NUP43 MCM5 TSC1 ECE1 CEP350 CCDC88C ALMS1 POC5 HERC2 ARHGEF2 TBC1D23 PC PCNT | 2.46e-06 | 853 | 161 | 16 | 28718761 |
| Pubmed | DAB2IP ANK3 PPP1R9A SPTBN1 RAPGEF4 DDN CNKSR2 EPB41L2 RASAL2 | 2.83e-06 | 251 | 161 | 9 | 27507650 | |
| Pubmed | IKZF3 TCF12 RSL1D1 SPTBN1 UBR4 ZNF507 MIDEAS TRRAP RNF214 FOXP4 LARP4B ALMS1 TLE3 SYNE2 KMT2A HERC2 TBR1 HERC1 SRRM2 SAP130 MYBL2 | 3.05e-06 | 1429 | 161 | 21 | 35140242 | |
| Pubmed | ANK3 EXPH5 SPTBN1 ARHGAP17 MUC12 MIDEAS MAP3K4 NSD3 CEP350 FHOD1 HERC2 EPB41L2 | 3.08e-06 | 486 | 161 | 12 | 20936779 | |
| Pubmed | Characterization of cDNA clones in size-fractionated cDNA libraries from human brain. | 6.31e-06 | 56 | 161 | 5 | 9455484 | |
| Pubmed | 8.01e-06 | 9 | 161 | 3 | 12154121 | ||
| Pubmed | TTF2 MARK3 PPP1R9A KIAA1549 DENND4C ANKRD44 CCDC88C ALMS1 ARHGEF2 UTRN RASAL2 | 8.11e-06 | 446 | 161 | 11 | 24255178 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | RSL1D1 MARK3 UBR4 SRPK2 MCM5 ALS2 TSC1 CNKSR2 TRRAP UBE4A TTBK2 TLE3 RIMS1 HERC2 ARHGEF2 HERC1 SRRM2 EPB41L2 RASAL2 | 8.48e-06 | 1284 | 161 | 19 | 17353931 |
| Pubmed | 9.87e-06 | 222 | 161 | 8 | 35941108 | ||
| Pubmed | Analysis of recently identified osteoporosis susceptibility genes in Han Chinese women. | 1.14e-05 | 10 | 161 | 3 | 20554715 | |
| Pubmed | Proteins recruited by SH3 domains of Ruk/CIN85 adaptor identified by LC-MS/MS. | 1.16e-05 | 108 | 161 | 6 | 19531213 | |
| Pubmed | DAB2IP CAND2 ANK3 RSL1D1 ZC3H13 SPTBN1 FRMPD1 ZNF507 MARCHF7 ALS2 EZHIP TTBK2 LARP4B OGDHL HERC1 UTRN PCNT | 1.25e-05 | 1084 | 161 | 17 | 11544199 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | DAB2IP ANK3 RSL1D1 MARK3 SEPTIN9 SPTBN1 EPS8L1 SYT7 DENND4C MB21D2 NUMB UTRN | 1.40e-05 | 565 | 161 | 12 | 25468996 |
| Pubmed | 1.40e-05 | 233 | 161 | 8 | 29518331 | ||
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | DAB2IP MARK3 EXPH5 PPP1R9A KIAA1549 JPH2 TSC1 SYT7 CRACDL NUMB EPB41L2 RASAL2 | 1.50e-05 | 569 | 161 | 12 | 30639242 |
| Pubmed | 1.56e-05 | 11 | 161 | 3 | 19146812 | ||
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 1.67e-05 | 313 | 161 | 9 | 38270169 | |
| Pubmed | CAND2 ANK3 RSL1D1 MARK3 CWC15 ZC3H13 SPTBN1 UBR4 TRIOBP KIAA1549 SRPK2 UBE4A SYNE2 NUMB HAX1 HERC2 SRRM2 EPB41L2 RASAL2 PCNT | 1.93e-05 | 1487 | 161 | 20 | 33957083 | |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | ESPN CAND2 SPTBN1 ARHGAP17 MYRFL WDR37 TRRAP DENND4C KCNH4 ORC1 ATXN3L HECW2 CRACDL YDJC HERC1 SAP130 RASAL2 CNTFR | 1.96e-05 | 1242 | 161 | 18 | 30973865 |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 18642054 | ||
| Pubmed | Emergence of two unrelated clones in acute myeloid leukemia with MLL-SEPT9 fusion transcript. | 2.13e-05 | 2 | 161 | 2 | 20682395 | |
| Pubmed | DISC1-kendrin interaction is involved in centrosomal microtubule network formation. | 2.13e-05 | 2 | 161 | 2 | 18955030 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 34099188 | ||
| Pubmed | Loss of RasGAP Tumor Suppressors Underlies the Aggressive Nature of Luminal B Breast Cancers. | 2.13e-05 | 2 | 161 | 2 | 27974415 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 14978793 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 15094396 | ||
| Pubmed | Functional analyses of Pericentrin and Syne-2 interaction in ciliogenesis. | 2.13e-05 | 2 | 161 | 2 | 30054381 | |
| Pubmed | FHOD1 interaction with nesprin-2G mediates TAN line formation and nuclear movement. | 2.13e-05 | 2 | 161 | 2 | 24880667 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 37431882 | ||
| Pubmed | A striatal-enriched intronic GPCR modulates huntingtin levels and toxicity. | 2.13e-05 | 2 | 161 | 2 | 25738228 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 17074766 | ||
| Pubmed | Genetic analysis and clinical picture of severe congenital neutropenia in Israel. | 2.13e-05 | 2 | 161 | 2 | 25284454 | |
| Pubmed | Persistent but Labile Synaptic Plasticity at Excitatory Synapses. | 2.13e-05 | 2 | 161 | 2 | 29802202 | |
| Pubmed | Intron-less processed Pcdhalpha genes in the central nervous system. | 2.13e-05 | 2 | 161 | 2 | 14697259 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 24934694 | ||
| Pubmed | DISC1 regulates expression of the neurotrophin VGF through the PI3K/AKT/CREB pathway. | 2.13e-05 | 2 | 161 | 2 | 26212236 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 20220065 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 28445587 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 20113838 | ||
| Pubmed | Fusion of MLL and MSF in adult de novo acute myelomonocytic leukemia (M4) with t(11;17)(q23;q25). | 2.13e-05 | 2 | 161 | 2 | 12095151 | |
| Pubmed | DAB2IP RSL1D1 SEPTIN9 ZC3H13 DENND4C LARP4B TLE3 NUMB ARHGEF2 SRRM2 EPB41L2 | 2.47e-05 | 503 | 161 | 11 | 16964243 | |
| Pubmed | 2.67e-05 | 255 | 161 | 8 | 15324660 | ||
| Pubmed | 2.74e-05 | 418 | 161 | 10 | 34709266 | ||
| Pubmed | DAB2IP ANK3 MARK3 PPP1R9A TRIOBP WDR37 NUMB UTRN EPB41L2 RASAL2 | 2.91e-05 | 421 | 161 | 10 | 36976175 | |
| Pubmed | 3.33e-05 | 263 | 161 | 8 | 34702444 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | TTF2 RSL1D1 CWC15 ZC3H13 NUP43 MIDEAS TRRAP NSD3 ORC1 SLF2 ZSCAN30 ABRAXAS1 MSL3 KMT2A PC SRRM2 SAP130 MYBL2 | 3.36e-05 | 1294 | 161 | 18 | 30804502 |
| Pubmed | 3.41e-05 | 14 | 161 | 3 | 19079262 | ||
| Pubmed | DAB2IP MARK3 FRMPD1 KIAA1549 OSBPL6 KCNQ2 NUMB HERC2 PC DAGLA | 3.47e-05 | 430 | 161 | 10 | 32581705 | |
| Pubmed | 3.73e-05 | 347 | 161 | 9 | 17114649 | ||
| Pubmed | 3.93e-05 | 197 | 161 | 7 | 36604605 | ||
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | ABCC4 TCF12 MARK3 SEPTIN9 SRPK2 MAP3K4 LARP4B VPS13D ARHGEF2 EPB41L2 MYBL2 | 4.38e-05 | 536 | 161 | 11 | 15840001 |
| Pubmed | ABCC4 TCF12 MARK3 SEPTIN9 SRPK2 MAP3K4 LARP4B VPS13D ARHGEF2 EPB41L2 MYBL2 | 4.53e-05 | 538 | 161 | 11 | 10512203 | |
| Pubmed | UBR4 MUC16 REV3L STK31 CEP350 TTBK2 TLE3 SYNE2 ARHGEF2 RASAL2 MYBL2 FAM149A | 4.56e-05 | 638 | 161 | 12 | 31182584 | |
| Pubmed | 4.96e-05 | 360 | 161 | 9 | 33111431 | ||
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | RSL1D1 ZC3H13 PPP1R9A SPTBN1 TRIOBP WDR37 ABRAXAS1 SRRM2 EPB41L2 | 5.06e-05 | 361 | 161 | 9 | 30344098 |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 5.06e-05 | 361 | 161 | 9 | 26167880 | |
| Pubmed | 5.44e-05 | 549 | 161 | 11 | 38280479 | ||
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 20945165 | ||
| Pubmed | Ankyrin-G is a molecular partner of E-cadherin in epithelial cells and early embryos. | 6.37e-05 | 3 | 161 | 2 | 17620337 | |
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 29632175 | ||
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 26770020 | ||
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 29569026 | ||
| Pubmed | Expanding our understanding of polyglutamine diseases through mouse models. | 6.37e-05 | 3 | 161 | 2 | 10595501 | |
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 19191256 | ||
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 32921582 | ||
| Interaction | PCDHA10 interactions | PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 | 3.83e-14 | 22 | 157 | 9 | int:PCDHA10 |
| Interaction | YWHAH interactions | DAB2IP MARK3 EXPH5 ZC3H13 SPTBN1 ARHGAP17 SIK1 ALS2 TSC1 ATAT1 WDR37 DENND4C NSD3 CEP350 CCDC88C VPS13D ALMS1 SSH1 SLF2 SYNE2 VASH2 OSBPL6 KMT2A NUMB RIMS1 ARHGEF2 HERC1 SRRM2 UTRN FRMD5 EPB41L2 RASAL2 HTT PCNT | 3.65e-12 | 1102 | 157 | 34 | int:YWHAH |
| Interaction | YWHAG interactions | DAB2IP MARK3 EXPH5 DISC1 ZC3H13 SPTBN1 ARHGAP17 SIK1 MCM5 ALS2 TSC1 ATAT1 WDR37 TRRAP DENND4C CEP350 CCDC88C VPS13D ALMS1 SSH1 SYNE2 VASH2 OSBPL6 KMT2A NUMB ARHGEF2 SRRM2 UTRN FRMD5 EPB41L2 RASAL2 HTT | 1.89e-09 | 1248 | 157 | 32 | int:YWHAG |
| Interaction | YWHAB interactions | DAB2IP MARK3 EXPH5 SPTBN1 SIK1 SRPK2 ALS2 TSC1 ATAT1 WDR37 TRRAP RGS3 DENND4C CEP350 CCDC88C VPS13D SSH1 VASH2 OSBPL6 KMT2A NUMB ARHGEF2 SRRM2 SAP130 FRMD5 EPB41L2 RASAL2 HTT | 4.67e-09 | 1014 | 157 | 28 | int:YWHAB |
| Interaction | PCDHA8 interactions | 1.01e-08 | 55 | 157 | 8 | int:PCDHA8 | |
| Interaction | YWHAQ interactions | DAB2IP CACNA1S MARK3 EXPH5 DISC1 ZC3H13 SIK1 ALS2 TSC1 ATAT1 WDR37 RGS3 DENND4C CEP350 CCDC88C VPS13D SSH1 VASH2 OSBPL6 KMT2A NUMB HAX1 ARHGEF2 PC FRMD5 EPB41L2 RASAL2 HTT | 3.80e-08 | 1118 | 157 | 28 | int:YWHAQ |
| Interaction | PCDHA7 interactions | 5.09e-08 | 14 | 157 | 5 | int:PCDHA7 | |
| Interaction | FLT3 interactions | TTF2 UBR4 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 TRRAP KMT2A ARHGEF2 | 2.05e-07 | 318 | 157 | 14 | int:FLT3 |
| Interaction | PCDHGA10 interactions | 2.87e-07 | 19 | 157 | 5 | int:PCDHGA10 | |
| Interaction | PCDHA1 interactions | 4.33e-07 | 9 | 157 | 4 | int:PCDHA1 | |
| Interaction | KALRN interactions | 8.42e-07 | 96 | 157 | 8 | int:KALRN | |
| Interaction | SYNGAP1 interactions | DAB2IP PITPNM2 SPTBN1 DDN TSC1 CNKSR2 SYNE2 KCNQ2 HAX1 ARHGEF2 EPB41L2 RASAL2 PCNT | 8.82e-07 | 307 | 157 | 13 | int:SYNGAP1 |
| Interaction | YWHAZ interactions | DAB2IP MARK3 EXPH5 DISC1 SPTBN1 SIK1 ALS2 TSC1 CNKSR2 ATAT1 WDR37 RGS3 DENND4C MAP3K4 CCDC88C VPS13D SSH1 FHOD1 SYNE2 OSBPL6 KMT2A NUMB HERC2 ARHGEF2 EPB41L2 RASAL2 HTT PCNT | 1.11e-06 | 1319 | 157 | 28 | int:YWHAZ |
| Interaction | CEP152 interactions | TTF2 ANK3 KIF1A SEPTIN9 KIAA1549 CEP350 RNF214 ALMS1 POC5 PCNT | 1.44e-06 | 179 | 157 | 10 | int:CEP152 |
| Interaction | PCDHA12 interactions | 1.47e-06 | 46 | 157 | 6 | int:PCDHA12 | |
| Interaction | DUSP16 interactions | KIF1A EXPH5 DISC1 BTBD10 DENND4C CEP350 ALMS1 BUB1 HAX1 HTT PCNT | 2.62e-06 | 237 | 157 | 11 | int:DUSP16 |
| Interaction | HRAS interactions | DAB2IP IKZF3 RASA1 MARK3 EXPH5 SEPTIN9 SPTBN1 KIAA1549 JPH2 TSC1 SYT7 HEATR6 CRACDL RIN2 BUB1 NUMB CCR1 EPB41L2 RASAL2 | 3.85e-06 | 725 | 157 | 19 | int:HRAS |
| Interaction | PCDHA9 interactions | 4.57e-06 | 32 | 157 | 5 | int:PCDHA9 | |
| Interaction | ALMS1 interactions | 5.68e-06 | 164 | 157 | 9 | int:ALMS1 | |
| Interaction | PCDHA3 interactions | 6.24e-06 | 34 | 157 | 5 | int:PCDHA3 | |
| Interaction | TNIK interactions | ANK3 DISC1 SPTBN1 RAPGEF4 TSC1 CNKSR2 SHISA7 SYNE2 KCNQ2 RIMS1 HERC2 ARHGEF2 HTT | 9.37e-06 | 381 | 157 | 13 | int:TNIK |
| Interaction | TRIM52 interactions | 9.76e-06 | 133 | 157 | 8 | int:TRIM52 | |
| Interaction | PCDHA11 interactions | 1.25e-05 | 19 | 157 | 4 | int:PCDHA11 | |
| Interaction | EPB41L4A interactions | 1.42e-05 | 140 | 157 | 8 | int:EPB41L4A | |
| Interaction | SPTBN1 interactions | ANK3 DISC1 SPTBN1 MCM5 CNKSR2 TRRAP SYNE2 KCNQ2 HERC2 SRRM2 HTT PCNT MYBL2 | 2.68e-05 | 421 | 157 | 13 | int:SPTBN1 |
| Interaction | KCTD13 interactions | PITPNM2 ANK3 MARK3 SEPTIN9 PPP1R9A SPTBN1 RAPGEF4 KIAA1549 SRPK2 TSC1 CNKSR2 WDR37 HECW2 CRACDL OSBPL6 KMT2A OGDHL KCNQ2 RIMS1 HAX1 ARHGEF2 PC UTRN DAGLA EPB41L2 RASAL2 | 2.80e-05 | 1394 | 157 | 26 | int:KCTD13 |
| Interaction | MLF1 interactions | 2.95e-05 | 113 | 157 | 7 | int:MLF1 | |
| Interaction | RHOB interactions | DAB2IP ANK3 RSL1D1 MARK3 PPP1R9A SPTBN1 TRIOBP KIAA1549 ARHGAP17 ZKSCAN5 CCDC88C OSBPL6 LRP4 NUMB ARHGEF2 HERC1 UTRN EPB41L2 RASAL2 | 3.03e-05 | 840 | 157 | 19 | int:RHOB |
| Interaction | PCDHA6 interactions | 3.76e-05 | 9 | 157 | 3 | int:PCDHA6 | |
| Interaction | ATOH1 interactions | 3.79e-05 | 80 | 157 | 6 | int:ATOH1 | |
| Interaction | TSPOAP1 interactions | 3.95e-05 | 25 | 157 | 4 | int:TSPOAP1 | |
| Interaction | CFAP184 interactions | 4.06e-05 | 162 | 157 | 8 | int:CFAP184 | |
| Interaction | AGAP2 interactions | DAB2IP ANK3 PPP1R9A SPTBN1 RAPGEF4 CNKSR2 RIMS1 EPB41L2 RASAL2 | 4.08e-05 | 210 | 157 | 9 | int:AGAP2 |
| Interaction | LATS1 interactions | RSL1D1 SPTBN1 KIAA1549 STK31 CEP350 CCDC88C ALMS1 HAX1 TBR1 SPINDOC SRRM2 PCNT SPIN3 | 4.23e-05 | 440 | 157 | 13 | int:LATS1 |
| Interaction | MAPRE1 interactions | KIF1A SEPTIN9 SPTBN1 NUP43 ARHGAP17 MARCHF7 SRPK2 CEP350 TTBK2 ALMS1 HERC2 ARHGEF2 SRRM2 PCNT | 5.15e-05 | 514 | 157 | 14 | int:MAPRE1 |
| Interaction | NUAK2 interactions | 7.46e-05 | 56 | 157 | 5 | int:NUAK2 | |
| Interaction | MAPRE3 interactions | 8.23e-05 | 230 | 157 | 9 | int:MAPRE3 | |
| Interaction | FBXO22 interactions | ANK3 RSL1D1 EXPH5 CWC15 SEPTIN9 SPTBN1 RAPGEF4 SIK1 TSC1 TRRAP MAP3K4 VPS13D KMT2A HERC1 | 8.72e-05 | 540 | 157 | 14 | int:FBXO22 |
| Interaction | GOLGA1 interactions | 9.59e-05 | 183 | 157 | 8 | int:GOLGA1 | |
| Interaction | SFN interactions | MARK3 EXPH5 SPTBN1 DENND4C CEP350 CCDC88C ALMS1 KMT2A NUMB CCR1 ARHGEF2 SRRM2 SAP130 EPB41L2 RASAL2 HTT | 1.04e-04 | 692 | 157 | 16 | int:SFN |
| Interaction | PCDHA4 interactions | 1.04e-04 | 60 | 157 | 5 | int:PCDHA4 | |
| Interaction | BAG2 interactions | TTF2 EXPH5 DISC1 ARHGAP17 MARCHF7 RNF214 VPS13D BUB1 KCNQ2 POC5 TBC1D23 SPINDOC SRRM2 RASAL2 HTT | 1.09e-04 | 622 | 157 | 15 | int:BAG2 |
| Interaction | YWHAE interactions | DAB2IP MARK3 EXPH5 DISC1 SIK1 ALS2 TSC1 ATAT1 WDR37 RGS3 DENND4C CCDC88C SSH1 OSBPL6 KMT2A NUMB ARHGEF2 SPINDOC SRRM2 SAP130 EPB41L2 RASAL2 HTT | 1.13e-04 | 1256 | 157 | 23 | int:YWHAE |
| Interaction | PCNT interactions | 1.17e-04 | 241 | 157 | 9 | int:PCNT | |
| Interaction | LONP2 interactions | 1.22e-04 | 62 | 157 | 5 | int:LONP2 | |
| Interaction | PRICKLE2 interactions | 1.22e-04 | 62 | 157 | 5 | int:PRICKLE2 | |
| Interaction | SPTAN1 interactions | ANK3 RSL1D1 DISC1 SPTBN1 MCM5 CNKSR2 TRRAP RNF6 SYNE2 KCNQ2 EPB41L2 HTT PCNT | 1.41e-04 | 496 | 157 | 13 | int:SPTAN1 |
| Interaction | PCDHA2 interactions | 1.59e-04 | 14 | 157 | 3 | int:PCDHA2 | |
| Interaction | SRGAP2 interactions | 1.60e-04 | 197 | 157 | 8 | int:SRGAP2 | |
| Interaction | RAB35 interactions | DAB2IP ANK3 MARK3 PPP1R9A SPTBN1 KIAA1549 ECE1 DENND4C SYNE2 NUMB UTRN EPB41L2 RASAL2 HTT | 1.62e-04 | 573 | 157 | 14 | int:RAB35 |
| Interaction | LYN interactions | DAB2IP ANK3 RASA1 MARK3 SEPTIN9 PPP1R9A SPTBN1 DENND4C CCDC88C KMT2A NUMB SRRM2 UTRN EPB41L2 RASAL2 HTT | 1.63e-04 | 720 | 157 | 16 | int:LYN |
| Interaction | TFDP3 interactions | 1.72e-04 | 36 | 157 | 4 | int:TFDP3 | |
| Interaction | PFN1 interactions | TTF2 SEPTIN9 SPTBN1 ARHGAP17 SRPK2 TSC1 DENND4C CEP350 ALMS1 FHOD1 SYNE2 HTT PCNT | 1.82e-04 | 509 | 157 | 13 | int:PFN1 |
| Interaction | PLK1 interactions | DAB2IP ANK3 KIF1A SEPTIN9 TRIOBP MCM5 TSC1 TRRAP ANKRD44 BUB1 OSBPL6 ARHGEF2 FAM131B | 1.85e-04 | 510 | 157 | 13 | int:PLK1 |
| Interaction | ZFPL1 interactions | ANK3 MARK3 DISC1 SPTBN1 KIAA1549 VPS13D MB21D2 OSBPL6 NUMB UTRN EPB41L2 RASAL2 | 2.09e-04 | 448 | 157 | 12 | int:ZFPL1 |
| Interaction | TAF4 interactions | 2.25e-04 | 156 | 157 | 7 | int:TAF4 | |
| Interaction | PRELID2 interactions | 2.91e-04 | 17 | 157 | 3 | int:PRELID2 | |
| Interaction | RND3 interactions | 2.98e-04 | 273 | 157 | 9 | int:RND3 | |
| Interaction | GUSBP5 interactions | 2.99e-04 | 75 | 157 | 5 | int:GUSBP5 | |
| Interaction | WHAMMP3 interactions | 3.42e-04 | 119 | 157 | 6 | int:WHAMMP3 | |
| Interaction | FLOT1 interactions | ANK3 MARK3 DISC1 SEPTIN9 SPTBN1 KIAA1549 NUMB HAX1 UTRN EPB41L2 RASAL2 HTT | 3.56e-04 | 475 | 157 | 12 | int:FLOT1 |
| Interaction | WDR49 interactions | 3.58e-04 | 4 | 157 | 2 | int:WDR49 | |
| Interaction | UPP1 interactions | 3.59e-04 | 78 | 157 | 5 | int:UPP1 | |
| Interaction | CIT interactions | GHDC RSL1D1 CWC15 DISC1 SEPTIN9 ZC3H13 SPTBN1 UBR4 NUP43 MCM5 PCDHA6 TRRAP MAP3K4 LARP4B ALMS1 HECW2 SYNE2 KMT2A ARHGEF2 HERC1 SRRM2 FRMD5 RASAL2 SPIN3 | 3.60e-04 | 1450 | 157 | 24 | int:CIT |
| Interaction | CALM1 interactions | RASA1 KIF1A DISC1 UBR4 DENND4C VPS13D SLF2 SYNE2 KCNQ2 POC5 HERC2 UTRN HTT PCNT | 3.98e-04 | 626 | 157 | 14 | int:CALM1 |
| Interaction | CTNNA1 interactions | ANK3 MARK3 SPTBN1 CEP350 CCDC88C NUMB HERC2 UTRN CDH8 EPB41L2 | 4.03e-04 | 347 | 157 | 10 | int:CTNNA1 |
| Interaction | EZR interactions | ANK3 MARK3 SEPTIN9 PPP1R9A TRIOBP KIAA1549 TSC1 WDR37 MB21D2 NUMB TBR1 UTRN RASAL2 | 4.03e-04 | 553 | 157 | 13 | int:EZR |
| Interaction | FTL interactions | 4.12e-04 | 348 | 157 | 10 | int:FTL | |
| Interaction | PCDHAC2 interactions | 4.12e-04 | 45 | 157 | 4 | int:PCDHAC2 | |
| Interaction | NFIX interactions | 4.16e-04 | 227 | 157 | 8 | int:NFIX | |
| Interaction | RAB5A interactions | RASA1 MARK3 UBR4 KIAA1549 TSC1 ECE1 DENND4C CCDC88C RIN2 SYNE2 NUMB CCR1 HAX1 HERC2 HTT | 4.23e-04 | 706 | 157 | 15 | int:RAB5A |
| Interaction | TTC3 interactions | 4.26e-04 | 124 | 157 | 6 | int:TTC3 | |
| Interaction | TOP3B interactions | DAB2IP PITPNM2 PPP1R9A UBR4 ARHGAP17 MCM5 REV3L ECE1 TRRAP NSD3 ORC1 CCDC88C LARP4B SSH1 LRP4 OGDHL KCNQ2 HERC2 ARHGEF2 HERC1 PC HTT PCNT MYBL2 | 4.39e-04 | 1470 | 157 | 24 | int:TOP3B |
| Interaction | MYCBP2 interactions | PPP1R9A SPTBN1 UBR4 SRPK2 PCDHA3 SSH1 SYNE2 HERC2 TBR1 ARHGEF2 | 4.81e-04 | 355 | 157 | 10 | int:MYCBP2 |
| Interaction | DCLK1 interactions | 4.84e-04 | 127 | 157 | 6 | int:DCLK1 | |
| Interaction | RAB2A interactions | MARK3 PPP1R9A SPTBN1 KIAA1549 TSC1 ECE1 DENND4C MB21D2 NUMB POC5 HAX1 EPB41L2 RASAL2 | 5.10e-04 | 567 | 157 | 13 | int:RAB2A |
| Cytoband | 5q31 | PCDHB13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDH12 | 3.63e-13 | 115 | 161 | 11 | 5q31 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | PCDHB13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDH12 PROB1 | 7.89e-10 | 298 | 161 | 12 | chr5q31 |
| Cytoband | 6q12-q13 | 1.21e-04 | 5 | 161 | 2 | 6q12-q13 | |
| Cytoband | 7q22 | 3.26e-04 | 38 | 161 | 3 | 7q22 | |
| Cytoband | 14q32.3 | 5.40e-04 | 10 | 161 | 2 | 14q32.3 | |
| Cytoband | 10p15.3 | 1.08e-03 | 14 | 161 | 2 | 10p15.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q22 | 1.09e-03 | 219 | 161 | 5 | chr7q22 | |
| GeneFamily | Clustered protocadherins | PCDHB13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 | 2.98e-12 | 64 | 104 | 10 | 20 |
| GeneFamily | Pleckstrin homology domain containing|SH2 domain containing|C2 and RasGAP domain containing | 2.15e-05 | 10 | 104 | 3 | 830 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.88e-04 | 206 | 104 | 7 | 682 | |
| GeneFamily | CD molecules|Mucins | 2.28e-04 | 21 | 104 | 3 | 648 | |
| GeneFamily | PDZ domain containing | 2.46e-04 | 152 | 104 | 6 | 1220 | |
| GeneFamily | VPS9 domain containing | 1.43e-03 | 10 | 104 | 2 | 928 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 2.98e-03 | 50 | 104 | 3 | 1293 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 4.72e-03 | 18 | 104 | 2 | 91 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | RASA1 SEPTIN9 SPTBN1 ALS2 TSC1 ALMS1 BUB1 ARHGEF2 EPB41L2 RASAL2 PCNT | 3.73e-08 | 199 | 158 | 11 | M5893 |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED | CCDC110 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 EZHIP | 5.72e-07 | 261 | 158 | 11 | MM1277 |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED | CCDC110 PCDHA12 PCDHA11 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 EZHIP | 1.95e-06 | 238 | 158 | 10 | M2020 |
| Coexpression | GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_DN | 2.32e-06 | 189 | 158 | 9 | M3112 | |
| Coexpression | GSE3982_MEMORY_CD4_TCELL_VS_TH1_UP | 3.26e-06 | 197 | 158 | 9 | M5378 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | ABCC4 CAND2 RASA1 KIF1A RSL1D1 SPTBN1 ARHGAP17 MARCHF7 SIK1 SRPK2 TSC1 WDR37 CEP350 UBE4A LARP4B SLF2 SYNE2 KMT2A CCR1 FCMR | 4.49e-05 | 1215 | 158 | 20 | M41122 |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP | TCF12 SPTBN1 NUP43 TSC1 ECE1 TRRAP CEP350 LARP4B POC5 HAX1 HERC2 FCMR SPIN3 | 4.68e-05 | 573 | 158 | 13 | M41006 |
| Coexpression | GSE11386_NAIVE_VS_MEMORY_BCELL_DN | 5.04e-05 | 158 | 158 | 7 | M372 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA1 | VGF TMEM74B ANK3 PCDHA7 TSC1 REV3L SYT7 IGDCC4 ANKRD44 VASH2 OSBPL6 RIMS1 FRMD5 | 5.68e-05 | 584 | 158 | 13 | M39068 |
| Coexpression | YOKOE_CANCER_TESTIS_ANTIGENS | 5.75e-05 | 35 | 158 | 4 | M12210 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | TCF12 RASA1 MARK3 SEPTIN9 MARCHF7 SRPK2 REV3L WDR37 TRRAP MAP3K4 CEP350 LARP4B RIN2 SYNE2 NUMB PCNT | 6.36e-05 | 856 | 158 | 16 | M4500 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | TCF12 TP53INP1 ANK3 SPTBN1 PCDHB13 KIAA1549 SIK1 ATAT1 RGS3 ANKRD44 SSC5D MB21D2 ALMS1 LRP4 TBC1D23 FRMD5 EPB41L2 HTT | 1.22e-04 | 1102 | 158 | 18 | M2369 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | VGF IKZF3 TMEM74B ANK3 KIF1A PPP1R9A KIAA1549 PCDHA7 REV3L ANKRD44 VASH2 OSBPL6 OGDHL RIMS1 HERC1 CDH8 FRMD5 RASAL2 | 1.28e-04 | 1106 | 158 | 18 | M39071 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | TCF12 RASA1 MARK3 SEPTIN9 MARCHF7 SRPK2 REV3L TRRAP CEP350 LARP4B NUMB | 1.29e-04 | 466 | 158 | 11 | M13522 |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | RSL1D1 MARK3 MARCHF7 SIK1 TSC1 ZKSCAN5 DENND4C TTBK2 RNF6 SLF2 CSNK1G1 NUMB ARHGEF2 RASAL2 PDZD2 | 1.41e-04 | 822 | 158 | 15 | M6782 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | TCF12 TP53INP1 ANK3 SPTBN1 PCDHB13 KIAA1549 SIK1 ATAT1 RGS3 ANKRD44 SSC5D MB21D2 ALMS1 LRP4 TBC1D23 FRMD5 EPB41L2 HTT | 1.56e-04 | 1124 | 158 | 18 | MM1070 |
| Coexpression | LAKE_ADULT_KIDNEY_C28_INTERSTITIUM | 1.76e-04 | 86 | 158 | 5 | M39247 | |
| Coexpression | LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES | 1.87e-04 | 137 | 158 | 6 | M39241 | |
| Coexpression | GSE29618_PRE_VS_DAY7_FLU_VACCINE_BCELL_DN | 1.93e-04 | 196 | 158 | 7 | M4973 | |
| Coexpression | GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_UP | 2.00e-04 | 197 | 158 | 7 | M6059 | |
| Coexpression | GSE13484_UNSTIM_VS_3H_YF17D_VACCINE_STIM_PBMC_UP | 2.12e-04 | 199 | 158 | 7 | M3257 | |
| Coexpression | GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_16H_DN | 2.12e-04 | 199 | 158 | 7 | M8259 | |
| Coexpression | GSE40273_XBP1_KO_VS_WT_TREG_DN | 2.12e-04 | 199 | 158 | 7 | M9124 | |
| Coexpression | GSE10239_KLRG1INT_VS_KLRG1HIGH_EFF_CD8_TCELL_DN | 2.12e-04 | 199 | 158 | 7 | M3070 | |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN | 2.16e-04 | 337 | 158 | 9 | M13206 | |
| Coexpression | GSE22025_UNTREATED_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP | 2.19e-04 | 200 | 158 | 7 | M8383 | |
| Coexpression | GSE5589_WT_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_DN | 2.19e-04 | 200 | 158 | 7 | M6650 | |
| Coexpression | GSE17721_POLYIC_VS_GARDIQUIMOD_16H_BMDC_UP | 2.19e-04 | 200 | 158 | 7 | M4031 | |
| Coexpression | GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_UP | 2.19e-04 | 200 | 158 | 7 | M7911 | |
| Coexpression | GSE6674_PL2_3_VS_ANTI_IGM_AND_CPG_STIM_BCELL_DN | 2.19e-04 | 200 | 158 | 7 | M6943 | |
| Coexpression | MARTINEZ_RESPONSE_TO_TRABECTEDIN | 2.36e-04 | 50 | 158 | 4 | M5077 | |
| CoexpressionAtlas | cerebral cortex | VGF SMIM13 KIF1A RAPGEF4 DDN PCDHA11 PCDHA7 GPR52 PCDHA6 PCDHA5 PCDHA4 CNKSR2 SYT7 SHISA7 KCNH4 CRACDL OSBPL6 LRP4 KCNQ2 RIMS1 TBR1 DAGLA CDH8 FRMD5 FAM131B CNTFR | 1.54e-05 | 1428 | 156 | 26 | cerebral cortex |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | PITPNM2 COL12A1 PPP1R9A SPTBN1 RAPGEF4 PCDH12 ECE1 SYNE2 KMT2A UTRN PCNT | 1.77e-10 | 200 | 160 | 11 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb |
| ToppCell | droplet-Liver-LIVER_HEP-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | DAB2IP SPTBN1 PCDH12 HECW2 KMT2A SPINDOC EPB41L2 RASAL2 CNTFR | 1.93e-08 | 180 | 160 | 9 | dd1b10c7f5a0fbc63163844ca1882884a24a84d3 |
| ToppCell | droplet-Liver-LIVER_HEP|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | DAB2IP SPTBN1 PCDH12 HECW2 KMT2A SPINDOC EPB41L2 RASAL2 CNTFR | 1.93e-08 | 180 | 160 | 9 | 423454e3390080ae03bb3cbb267255ebfe4df080 |
| ToppCell | moderate-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.68e-08 | 194 | 160 | 9 | dff3fb10372053951d41e0ccd41aac3ece6009bd | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|lung / Disease (COVID-19 only), tissue and cell type | THSD4 PITPNM2 SPTBN1 RAPGEF4 PCDH12 HECW2 SYNE2 EPB41L2 RASAL2 | 4.02e-08 | 196 | 160 | 9 | 4ac4073380d939a73cec7413e9f3f5ef616d2924 |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.20e-08 | 197 | 160 | 9 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.78e-08 | 200 | 160 | 9 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | COPD-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 4.15e-07 | 188 | 160 | 8 | 1aa0e35b1c28ac847886fece16c3ef7fc6fcdd51 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.50e-07 | 190 | 160 | 8 | 0e9847d7f49b2236b8a191e1a7df37556351ba9e | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.68e-07 | 191 | 160 | 8 | f229abf69a1217194f74b0502486907e07dba989 | |
| ToppCell | Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|World / Lineage, Cell type, age group and donor | 4.87e-07 | 192 | 160 | 8 | 1e156bab5ecf64627890d2de9b27603d9a01f28d | |
| ToppCell | droplet-Fat-Gat-18m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.12e-07 | 132 | 160 | 7 | 4152529611eeacf0c547e2a134d5b98c45426b13 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.27e-07 | 194 | 160 | 8 | 68004855b23fe1e31e8452d70effabc78a4a0bd3 | |
| ToppCell | IPF-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 5.27e-07 | 194 | 160 | 8 | 777ce41c3f22c591e2d81120f189b834e53ffb4b | |
| ToppCell | LV-09._Endothelium_I|World / Chamber and Cluster_Paper | 5.48e-07 | 195 | 160 | 8 | 19e0a6c3eae1615aaa39767300acd937dfcb2a7f | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.48e-07 | 195 | 160 | 8 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.48e-07 | 195 | 160 | 8 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.70e-07 | 196 | 160 | 8 | 49cc0a2b9739abad61dff7292ea0b14d28ff35c4 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.92e-07 | 197 | 160 | 8 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.63e-07 | 200 | 160 | 8 | 105c67e4f5eff036013d655c8e8ac577d32dae2e | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.79e-06 | 170 | 160 | 7 | b1a16600754e0c12f7d39c9221f1b03135833f16 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.38e-06 | 175 | 160 | 7 | 26bd957498e41a3f1ffa60d3effa27ca8c4ba631 | |
| ToppCell | wk_15-18-Epithelial-PNS-KCNIP4+_neuron|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.92e-06 | 179 | 160 | 7 | e20bfdfb6d5af8556eb66b81a19fbe4e3e28334a | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 4.87e-06 | 185 | 160 | 7 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.87e-06 | 185 | 160 | 7 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | Control-Endothelial-VE_Capillary_A|World / Disease state, Lineage and Cell class | 4.87e-06 | 185 | 160 | 7 | a28187c2fd23564314b35759479ff2ca21f61485 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.04e-06 | 186 | 160 | 7 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.04e-06 | 186 | 160 | 7 | 7278a1a1bf9bb27aeb03852134defb31b62f30d6 | |
| ToppCell | Control-Endothelial-VE_Capillary_A|Control / Disease state, Lineage and Cell class | 5.23e-06 | 187 | 160 | 7 | 54d7588172ac145ff5045ad9771636729ca3f0ca | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D122|Adult / Lineage, Cell type, age group and donor | 5.41e-06 | 188 | 160 | 7 | 02a62888e9db29d20133eeca1686d302545a39c9 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-FOXN4+|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.80e-06 | 190 | 160 | 7 | 250ca4a605c1cccd77d23383e4fe6f91cf3609ba | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.21e-06 | 192 | 160 | 7 | 4bab9754cfd8b9c2d7cc1490e8a29f58c3c26f6c | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.43e-06 | 193 | 160 | 7 | 826b8dd801298b3e0cd76232feae5a14026b8806 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.43e-06 | 193 | 160 | 7 | 87d3a577d37fb0cb4b6313c596310de452bc3872 | |
| ToppCell | Control-Endothelial-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.43e-06 | 193 | 160 | 7 | aff0649c73c634bc6ff0dc7759b4693a9236bf05 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.43e-06 | 193 | 160 | 7 | af5108260783e69a7d67896c5bf64f862525926d | |
| ToppCell | Control-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.43e-06 | 193 | 160 | 7 | c5f9fe03e64c211d4bcd4959e5b32f14841e336a | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.43e-06 | 193 | 160 | 7 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.43e-06 | 193 | 160 | 7 | d485634c564b268e344b6a2863c26f6adaec9e38 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.65e-06 | 194 | 160 | 7 | 71ac69cdf7a08ca3ddfb5b492b14ac56b6cd5e5d | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.65e-06 | 194 | 160 | 7 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.65e-06 | 194 | 160 | 7 | ad6c04ad0621689e3bf4c94ccd6e60653bbd02c7 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 6.65e-06 | 194 | 160 | 7 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.65e-06 | 194 | 160 | 7 | 0b023de48ed8a550d169bbe954881eb04bf4f981 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.65e-06 | 194 | 160 | 7 | 40842a7160f337bfc191ee15fbda3e3d38a04c57 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.87e-06 | 195 | 160 | 7 | 4b9663509cc5e3f409f6d0d37640cb301a827d98 | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.87e-06 | 195 | 160 | 7 | bd8e24dd598990204998d1dd853ba7a53dc0107e | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasmablast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.87e-06 | 195 | 160 | 7 | c6e31038be2463f1601d52c82efa4e9facb8228f | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.87e-06 | 195 | 160 | 7 | e7230a849ea31e6eef9bc6f5468938499450582d | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 7.11e-06 | 196 | 160 | 7 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.11e-06 | 196 | 160 | 7 | ea8eceacc5d5e1a22b77c31e7c45985dc7bb15de | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.11e-06 | 196 | 160 | 7 | 8f2031b1a9232c389517fbf3c29f47f9468b0077 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.11e-06 | 196 | 160 | 7 | c225c8eb2fe9a10f0cf574c7d8b6206887aac2df | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.11e-06 | 196 | 160 | 7 | 48b4a9cea97a55190217deaf51bf867608c5a9a7 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.11e-06 | 196 | 160 | 7 | 473980c827443464d08a0be28c53e3536369b12a | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_alveolar-Dividing_AT2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.35e-06 | 197 | 160 | 7 | 49689a03ab31e53386dbe15c77c09ca3a14ebf4e | |
| ToppCell | LV-09._Endothelium_I|LV / Chamber and Cluster_Paper | 7.35e-06 | 197 | 160 | 7 | f9731d4d636e51b94a96805eee6afe9aedc175e3 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-IPC_like|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 7.59e-06 | 198 | 160 | 7 | 6d12ecaa9532c134d9c4562534dcb59a6420b4d3 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 7.59e-06 | 198 | 160 | 7 | 85f424cd9bb3117c9e322031024aabb87696ce47 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-IPC_like-IPs_and_early_cortical_neurons|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 7.59e-06 | 198 | 160 | 7 | 7943e4f67c3d6efb5c8b00aa0ff3cfe7be10c48d | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 7.59e-06 | 198 | 160 | 7 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_capillary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.11e-06 | 200 | 160 | 7 | 2d962c9d63e9e5f1a06870e383609672e7b1738c | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.11e-06 | 200 | 160 | 7 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 8.11e-06 | 200 | 160 | 7 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 8.11e-06 | 200 | 160 | 7 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.11e-06 | 200 | 160 | 7 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-Plasma_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.73e-05 | 150 | 160 | 6 | 8b781ec3e6c2adf052d46d724e2aef72b0c27d13 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-Plasma_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.73e-05 | 150 | 160 | 6 | 17da17f01a3d41ac7df20f806e3eae30eca06982 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Lymphocytic_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.73e-05 | 150 | 160 | 6 | 8702d5bb419d5e997d388e8f7e0365ba5d1de8d5 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 2.15e-05 | 156 | 160 | 6 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-FB-1|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.40e-05 | 159 | 160 | 6 | b4bc888e978b1b577721b891b0af6ba9a1607044 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.66e-05 | 162 | 160 | 6 | 80317c4253bf8e897782e562f29835f181c65b98 | |
| ToppCell | Control-Lymphocyte-B-Plasmablast|Control / Disease, Lineage and Cell Type | 2.66e-05 | 162 | 160 | 6 | 67b32c40cc180c5ebbfd901a417b5be469500110 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 2.66e-05 | 162 | 160 | 6 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-plasma_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.85e-05 | 164 | 160 | 6 | b92e7c91910d518627376166c6ea9ed333b3d07e | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-plasma_cell-plasma_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.85e-05 | 164 | 160 | 6 | a1e43c6b3e2553f5604100db6e92bf244b70c36d | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-05 | 165 | 160 | 6 | 1b7dfa173e83aa8c46a3153a3261866c065c3b73 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-05 | 165 | 160 | 6 | b4f7d33af7d053ec07b01bd67d861600a9c4822e | |
| ToppCell | droplet-Fat-SCAT-30m-Lymphocytic-B_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-05 | 166 | 160 | 6 | 4b31d2755108b2815316411a38bfb11fd30ef98a | |
| ToppCell | 343B-Myeloid-Mast_cell-|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.06e-05 | 166 | 160 | 6 | 4e47e7f3019fb2dcbc35b4e9b47ee265a97cec5c | |
| ToppCell | 343B-Myeloid-Mast_cell|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.06e-05 | 166 | 160 | 6 | f6e2ec767c022982ef416fadb998a7b6b958f76a | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-inner_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-05 | 100 | 160 | 5 | 97ca9cda55a05fbb4d1f5d61f847c965e014f05c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.16e-05 | 167 | 160 | 6 | 83969c36ac44b96afc9aa09400a99fa2b487f7ff | |
| ToppCell | COVID-19-lung-MAST|lung / Disease (COVID-19 only), tissue and cell type | 3.49e-05 | 170 | 160 | 6 | e90f18e5462381b38e918442b38b1c8105291908 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.49e-05 | 170 | 160 | 6 | a965e3ee6818790a4a6916824fde64333d9b11b7 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.73e-05 | 172 | 160 | 6 | 3a37569a5902f3c65ff8d3912421309a8c82ee9b | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic-Mast_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.73e-05 | 172 | 160 | 6 | cc9d9dae290f11f8c348c78228af4e49469dc93b | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.73e-05 | 172 | 160 | 6 | 7c238a7375341d4647ba7274d93fddfb6fae7ce4 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-05 | 174 | 160 | 6 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.98e-05 | 174 | 160 | 6 | ae363ce736fc8af439f3ad594d7bc2e344db80d4 | |
| ToppCell | droplet-Lung-nan-21m-Lymphocytic-Plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-05 | 174 | 160 | 6 | 3f4277763e312b46ebd4401ea4a2f5d4c850c768 | |
| ToppCell | droplet-Lung-nan-21m-Lymphocytic-plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-05 | 174 | 160 | 6 | fad66d1a8407574b6a835e0bdb824a53afa58650 | |
| ToppCell | Influenza_Severe-Plasmablast|Influenza_Severe / Disease group and Cell class | 4.10e-05 | 175 | 160 | 6 | 3f9b9793d3d1b7a9b97899272b6a0d37b05c11d1 | |
| ToppCell | COVID-19-lung-MAST|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.24e-05 | 176 | 160 | 6 | 473c45a381ca109207d66ed1635668b391ea0e1f | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.24e-05 | 176 | 160 | 6 | 3bbac5c2397535631fce8fa98f6ddb4fe0260351 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 4.37e-05 | 177 | 160 | 6 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | LA-17._Lymphocyte|World / Chamber and Cluster_Paper | 4.51e-05 | 178 | 160 | 6 | 34ec499d03cc198cfefa19a724d4c81974052f65 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.51e-05 | 178 | 160 | 6 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.51e-05 | 178 | 160 | 6 | 93ce73f8bcec63ebf86fabb546f88400e8f06465 | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_macrophage-stroma-erythroid_macrophage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.66e-05 | 179 | 160 | 6 | c17ae394b855f01f8ca1765c416fd8b34a96e60b | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.46e-05 | 49 | 87 | 5 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Drug | Azacitidine | LAMA1 PCDHA12 PCDHA11 PCDHA8 PCDHA7 MCM5 PCDHA6 PCDHA5 PCDHA4 TSC1 PCDHA3 PCDHA2 ARHGEF2 | 7.92e-06 | 415 | 160 | 13 | ctd:D001374 |
| Drug | Bupivacaine hydrochloride [18010-40-7]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 8.64e-06 | 191 | 160 | 9 | 7435_DN | |
| Drug | Pinacidil [85371-64-8]; Down 200; 16.4uM; HL60; HT_HG-U133A | 1.06e-05 | 196 | 160 | 9 | 2406_DN | |
| Drug | Trimethylcolchicinic acid [3482-37-9]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 1.11e-05 | 197 | 160 | 9 | 4787_DN | |
| Drug | Benzethonium chloride [121-54-0]; Down 200; 9uM; HL60; HT_HG-U133A | 5.92e-05 | 189 | 160 | 8 | 2508_DN | |
| Drug | Chloroquine diphosphate [50-63-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 6.14e-05 | 190 | 160 | 8 | 2869_DN | |
| Drug | Sanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A | 6.37e-05 | 191 | 160 | 8 | 4168_DN | |
| Drug | Metergoline [17692-51-2]; Down 200; 10uM; MCF7; HT_HG-U133A | 6.86e-05 | 193 | 160 | 8 | 3221_DN | |
| Drug | Etanidazole [22668-01-5]; Down 200; 18.6uM; MCF7; HT_HG-U133A | 7.11e-05 | 194 | 160 | 8 | 6072_DN | |
| Drug | Flutamide [13311-84-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 7.11e-05 | 194 | 160 | 8 | 4361_DN | |
| Drug | (S)-(-)-Atenolol [93379-54-5]; Up 200; 15uM; MCF7; HT_HG-U133A | 7.37e-05 | 195 | 160 | 8 | 5325_UP | |
| Drug | Cimetidine [51481-61-9]; Up 200; 15.8uM; PC3; HG-U133A | 7.37e-05 | 195 | 160 | 8 | 1884_UP | |
| Drug | Ethionamide [536-33-4]; Down 200; 24uM; MCF7; HT_HG-U133A | 7.37e-05 | 195 | 160 | 8 | 4418_DN | |
| Drug | Hydralazine hydrochloride [304-20-1]; Down 200; 20.4uM; PC3; HT_HG-U133A | 7.64e-05 | 196 | 160 | 8 | 3724_DN | |
| Drug | Pimozide [2062-78-4]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 7.64e-05 | 196 | 160 | 8 | 6780_DN | |
| Drug | Mesoridazine besylate [32672-69-8]; Down 200; 7.4uM; MCF7; HT_HG-U133A | 7.64e-05 | 196 | 160 | 8 | 7017_DN | |
| Drug | Sulfadimethoxine [122-11-2]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 7.64e-05 | 196 | 160 | 8 | 3441_UP | |
| Drug | Hydrastine hydrochloride [5936-28-7]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 7.92e-05 | 197 | 160 | 8 | 6011_DN | |
| Drug | Chlormezanone [80-77-3]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 7.92e-05 | 197 | 160 | 8 | 3235_DN | |
| Drug | 15(S)-15-methyl Prostaglandin E2; Up 200; 10uM; MCF7; HT_HG-U133A | 7.92e-05 | 197 | 160 | 8 | 7521_UP | |
| Drug | Rauwolscine hydrochloride [6211-32-1]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 7.92e-05 | 197 | 160 | 8 | 6274_UP | |
| Drug | Catechin-(+,-) hydrate [7295-85-4]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 7.92e-05 | 197 | 160 | 8 | 3351_UP | |
| Drug | Flufenamic acid [530-78-9]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 7.92e-05 | 197 | 160 | 8 | 2267_DN | |
| Drug | Nadide [53-84-9]; Down 200; 6uM; MCF7; HT_HG-U133A | 7.92e-05 | 197 | 160 | 8 | 6091_DN | |
| Drug | (1)-Nipecotic acid [498-95-3]; Down 200; 31uM; MCF7; HT_HG-U133A | 7.92e-05 | 197 | 160 | 8 | 5999_DN | |
| Drug | Clioquinol [130-26-7]; Down 200; 13uM; MCF7; HT_HG-U133A | 8.20e-05 | 198 | 160 | 8 | 5258_DN | |
| Drug | dexamethasone; Up 200; 1uM; MCF7; HG-U133A | 8.20e-05 | 198 | 160 | 8 | 123_UP | |
| Drug | Chlorhexidine [55-56-1]; Up 200; 8uM; PC3; HG-U133A | 8.20e-05 | 198 | 160 | 8 | 1942_UP | |
| Drug | Bucladesine sodium salt [16980-89-5]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 8.80e-05 | 200 | 160 | 8 | 3483_UP | |
| Drug | Pentetic acid [67-43-6]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 8.80e-05 | 200 | 160 | 8 | 5264_DN | |
| Disease | 1,5 anhydroglucitol measurement | PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 | 2.63e-14 | 29 | 158 | 9 | EFO_0008009 |
| Disease | visceral adipose tissue measurement, body mass index | PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 CNKSR2 | 4.08e-11 | 87 | 158 | 10 | EFO_0004340, EFO_0004765 |
| Disease | neutrophil count, basophil count | PCDHA12 PCDHA11 PCDHA8 MARCHF7 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 CSNK1G1 | 3.82e-08 | 224 | 158 | 11 | EFO_0004833, EFO_0005090 |
| Disease | vital capacity | CACNA1S CAND2 KIF1A SEPTIN9 FRMPD1 JPH2 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 STK31 OSBPL6 HAX1 PC UTRN DAGLA EPB41L2 PDZD2 | 1.99e-07 | 1236 | 158 | 23 | EFO_0004312 |
| Disease | post-traumatic stress disorder symptom measurement | 3.00e-07 | 82 | 158 | 7 | EFO_0008535 | |
| Disease | depressive symptom measurement | PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 CNKSR2 ECE1 SYNE2 LRP4 KMT2A HERC1 DAGLA | 3.47e-06 | 426 | 158 | 12 | EFO_0007006 |
| Disease | Abnormality of refraction | ANK3 SEPTIN9 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 CNKSR2 RGS3 UTRN DAGLA | 3.66e-06 | 673 | 158 | 15 | HP_0000539 |
| Disease | 1-stearoylglycerol 1-monostearin measurement | 2.85e-05 | 2 | 158 | 2 | EFO_0021111 | |
| Disease | neutrophil count | SEPTIN9 SPTBN1 PCDHA12 PCDHA11 PCDHA8 MARCHF7 PCDHA7 SRPK2 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 ZKSCAN5 CSNK1G1 VASH2 LRP4 POC5 HTT PCNT | 5.22e-05 | 1382 | 158 | 20 | EFO_0004833 |
| Disease | neuroticism measurement, cognitive function measurement | ZNF507 DDN PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 ECE1 | 5.76e-05 | 566 | 158 | 12 | EFO_0007660, EFO_0008354 |
| Disease | pulse pressure measurement | THSD4 TP53INP1 MARK3 TRIOBP JPH2 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 DENND4C KCNH4 NSD3 YDJC POC5 SPINDOC | 5.77e-05 | 1392 | 158 | 20 | EFO_0005763 |
| Disease | Depression, Bipolar | 6.77e-05 | 79 | 158 | 5 | C0005587 | |
| Disease | post-traumatic stress disorder | 1.13e-04 | 202 | 158 | 7 | EFO_0001358 | |
| Disease | bipolar disorder | 2.94e-04 | 577 | 158 | 11 | MONDO_0004985 | |
| Disease | creatinine measurement, glomerular filtration rate | 4.27e-04 | 117 | 158 | 5 | EFO_0004518, EFO_0005208 | |
| Disease | Child Development Disorders, Specific | 4.97e-04 | 29 | 158 | 3 | C0085997 | |
| Disease | Child Development Deviations | 4.97e-04 | 29 | 158 | 3 | C0085996 | |
| Disease | Developmental Disabilities | 5.50e-04 | 30 | 158 | 3 | C0008073 | |
| Disease | Manic Disorder | 5.82e-04 | 71 | 158 | 4 | C0024713 | |
| Disease | Severe congenital neutropenia | 5.88e-04 | 7 | 158 | 2 | cv:C1853118 | |
| Disease | Manic | 8.30e-04 | 78 | 158 | 4 | C0338831 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 1.13e-03 | 145 | 158 | 5 | DOID:1289 (implicated_via_orthology) | |
| Disease | estrogen measurement | 1.25e-03 | 10 | 158 | 2 | EFO_0011007 | |
| Disease | decadienedioic acid (C10:2-DC) measurement | 1.25e-03 | 10 | 158 | 2 | EFO_0800598 | |
| Disease | eye color | 1.41e-03 | 90 | 158 | 4 | EFO_0003949 | |
| Disease | Neurodevelopmental Disorders | 1.60e-03 | 93 | 158 | 4 | C1535926 | |
| Disease | Congenital neutropenia | 1.82e-03 | 12 | 158 | 2 | C0340970 | |
| Disease | acute myeloid leukemia (implicated_via_orthology) | 1.82e-03 | 12 | 158 | 2 | DOID:9119 (implicated_via_orthology) | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 2.32e-03 | 49 | 158 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | Autistic Disorder | 2.90e-03 | 261 | 158 | 6 | C0004352 | |
| Disease | Intellectual Disability | 2.91e-03 | 447 | 158 | 8 | C3714756 | |
| Disease | RS-10-hydroxywarfarin to RS-warfarin ratio measurement | 2.94e-03 | 110 | 158 | 4 | EFO_0803335 | |
| Disease | plasminogen activator inhibitor 1 measurement | 3.06e-03 | 54 | 158 | 3 | EFO_0004792 | |
| Disease | Small cell carcinoma of lung | 3.06e-03 | 54 | 158 | 3 | C0149925 | |
| Disease | cognitive function measurement, self reported educational attainment | 3.12e-03 | 355 | 158 | 7 | EFO_0004784, EFO_0008354 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 4.08e-03 | 195 | 158 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | level of Phosphatidylcholine (20:4_0:0) in blood serum | 4.12e-03 | 18 | 158 | 2 | OBA_2045110 | |
| Disease | Tourette syndrome, schizophrenia | 4.12e-03 | 18 | 158 | 2 | EFO_0004895, MONDO_0005090 | |
| Disease | level of Phosphatidylcholine (16:0_22:5) in blood serum | 4.12e-03 | 18 | 158 | 2 | OBA_2045079 | |
| Disease | Bipolar Disorder | 4.30e-03 | 477 | 158 | 8 | C0005586 | |
| Disease | cutaneous melanoma, hair color | 4.52e-03 | 62 | 158 | 3 | EFO_0000389, EFO_0003924 | |
| Disease | Chronic myeloproliferative disorder | 4.59e-03 | 19 | 158 | 2 | C1292778 | |
| Disease | X-24309 measurement | 5.08e-03 | 20 | 158 | 2 | EFO_0800872 | |
| Disease | pars triangularis volume measurement | 5.08e-03 | 20 | 158 | 2 | EFO_0010321 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TPSIITESCSTHRLE | 136 | Q6UWZ7 | |
| SRDSSHERTESQLTP | 71 | Q9BSF8 | |
| RLTETHLPAQARTSE | 146 | O43683 | |
| HASTALSPSTETLDR | 271 | Q96Q42 | |
| TTSRRQHRDSPEILS | 1326 | Q96Q42 | |
| TDRLDLPVTTRSVHR | 906 | Q92974 | |
| HERSSSVSTIDTARL | 3776 | Q8TCU4 | |
| PRILEASSRHVESSS | 61 | A8MU93 | |
| RDRPTREHTTSSSVS | 76 | Q9P013 | |
| SRIRRHTAPDSDTDE | 616 | O94850 | |
| EPTAQDSLHVSITRR | 441 | Q9NRI5 | |
| ASRTSTPALVHTLDD | 511 | Q8TDY8 | |
| DSSTLHAVTFLRTPE | 171 | Q8NFH3 | |
| PDTTEHSRTDLSRDL | 981 | P20936 | |
| ETILANRSHSDSTPL | 21 | P49796 | |
| HSSRPFLLTTIVARD | 611 | Q9NPG4 | |
| ISTTRALDEADSPRH | 631 | Q9Y5H9 | |
| ISTTRVLDEADSPRH | 631 | Q9UN73 | |
| SSASIFEHVDRISRP | 1461 | Q9HCM3 | |
| ENILPHSTSRSRITL | 901 | Q9P2P5 | |
| ISTTRALDETDAPRH | 631 | Q9UN72 | |
| SRSHESLLSPSSAVE | 131 | Q5VWQ8 | |
| TLPRTTSRFSHSELD | 11276 | Q8WXI7 | |
| STTRALDEADSPRHR | 631 | Q9Y5I1 | |
| PALHIRSVSATDRDS | 466 | Q9Y5F0 | |
| RTIHPESSTSASRSL | 541 | Q8NA72 | |
| ISTTRVLDEADSPRH | 631 | Q9Y5H6 | |
| ISTTRALDEVDAPRH | 631 | Q9Y5H8 | |
| RSPLRTSLSSLRSEH | 156 | Q9BR39 | |
| TETTVTRHEADSSPR | 236 | O00165 | |
| STARSHEFSREPSLS | 111 | Q9H063 | |
| SSVRSDPAEHLRTAI | 401 | Q8IYB1 | |
| HERDSDRRSSIPITV | 596 | P33992 | |
| TATLERLSRPSTTHT | 706 | A5PLN7 | |
| RLSRPSTTHTFRQSD | 711 | A5PLN7 | |
| RRVRPQASLTATHSS | 2126 | O95714 | |
| ASAITRESHTHRDRP | 346 | Q9HCP0 | |
| SVEHRVLSRDPSAEL | 331 | B1AK53 | |
| ALLSHASEARPATRS | 201 | Q86X51 | |
| IHVDSRPFASLSRDS | 241 | Q9BUM1 | |
| ADVHSVSERPRSSTD | 141 | Q15751 | |
| RETHSVDRLPSALTA | 616 | Q92615 | |
| SPHRGSLDRTDASTD | 1491 | Q9P219 | |
| HERPTTSSRAIESDL | 311 | Q9H3M9 | |
| APHFERTSSKRVSRS | 536 | O43491 | |
| LRDSDTSISIPSVDH | 781 | O43526 | |
| PSVVHESRSAVSSRT | 91 | Q9ULD0 | |
| RSASETSTPHNTRRV | 1306 | O15018 | |
| RRSTHLSESESLPEH | 141 | A6H8Z2 | |
| ATSSRRRPLHDSAAL | 161 | Q99081 | |
| RSTDISTFRNHLPLT | 86 | Q8N2G8 | |
| ERPRESSCHIVTISS | 316 | Q8TDV5 | |
| EPEALQSLRRSTRHS | 341 | Q8N5Y2 | |
| RPDDSSSARTEIHLL | 41 | Q6AI08 | |
| SSRAVSASSPRRAVH | 591 | Q96LU7 | |
| ESRSHESLLSPCSTV | 86 | Q9UJF2 | |
| SGDDDTPITSRHTLV | 251 | Q9UQ05 | |
| TPSLLRHSFQSRSDT | 1001 | Q9UQ05 | |
| LESSTLHVTPRSLDR | 16 | Q8IWV1 | |
| TESLLSRNSESPEHV | 116 | Q8IWV1 | |
| SISVPTSDHRSLIEA | 991 | Q8NEV8 | |
| QPTVLTSRRDSSSHE | 281 | Q8IVH2 | |
| TPLHRAVASRSEEAV | 76 | Q8N8A2 | |
| STTRSLDETEAPRHR | 631 | Q9Y5H7 | |
| ESSRHLSRSNVDIPR | 636 | Q9BZ72 | |
| RARFPSHEVDSSRET | 241 | Q9Y2T5 | |
| IHILERTASSSTEPS | 36 | Q9BZF3 | |
| RSLTASQDPEHSLTE | 3291 | O95613 | |
| PDHVSDSTVSARISD | 186 | Q6NV74 | |
| SLHRPSTEQTRTDFS | 11 | Q86XD5 | |
| ASRSPVDHRTRDVDS | 996 | Q86UR5 | |
| RLESTTRSPVFSHLS | 891 | O15439 | |
| ISTTRALDETDAPRH | 631 | Q9UN74 | |
| EATSTPHRIRRKSSV | 371 | Q13415 | |
| ESLRDSAHSTPVRST | 381 | Q7Z6J6 | |
| FLPHVRSSRTDSNER | 401 | Q7Z6J6 | |
| SSSPARVTRREDLTH | 1101 | Q711Q0 | |
| EPVSRLLESTLRSSH | 2761 | P42858 | |
| EAPSNLVISERTHRS | 1386 | Q99715 | |
| SLHEETPHSRSTREN | 1761 | Q13698 | |
| LERVSSTSPSTGEHE | 336 | P32246 | |
| ESHPEVSASLRVATS | 1301 | Q5SYB0 | |
| PRHLTTEAQAAETTT | 306 | P26992 | |
| EQSFRSLLPSESHRR | 1621 | Q5VT06 | |
| TTAFIHALERRSSLP | 1266 | Q5VZ89 | |
| ERSTSLSALVRSSPH | 1321 | Q5VZ89 | |
| DQPSRRSESSAVSHI | 2946 | Q12955 | |
| SLLERSSTHIRSLEP | 506 | Q9BSJ5 | |
| SPRGSHSSALERLET | 81 | Q8IV03 | |
| RIPTSDTSSRSHIFR | 411 | Q9H992 | |
| THSISSAATPDRIRF | 541 | P27448 | |
| AHRTLLRTNSAEVTP | 691 | Q6PJG2 | |
| LRATRHSRAAAVDPT | 201 | Q5SQI0 | |
| LELPTADHRNSSVRS | 711 | Q9Y4D2 | |
| LSSLESSRRVHTSTP | 2801 | Q03164 | |
| SVRTPESSHEGLITD | 716 | P42892 | |
| TSSPIRFSIDRHTDL | 421 | P55286 | |
| LLTSRPEDTTHNRRS | 1056 | Q9Y613 | |
| ASSVRRPHLTSDAVA | 366 | Q8TE68 | |
| LERHVVSFDSSRPTS | 101 | Q9UKT9 | |
| STASRLVCDARSPHS | 821 | O75155 | |
| SSRAASVSSLHERIL | 411 | Q12756 | |
| ISTTRILDEADAPRH | 631 | Q9UN75 | |
| RLASADRHTEVPTGT | 596 | P49757 | |
| HVTFPRAEATRTALS | 31 | Q9H195 | |
| RAEATRTALSNSPHS | 36 | Q9H195 | |
| TRLTHSRDTEELQSP | 336 | Q9UNW8 | |
| ELQFRSLSRHSSPTE | 1241 | Q9Y6R4 | |
| HDESDRRTEPRSSVS | 91 | O43581 | |
| SASDIPVQSHRTSEI | 2211 | P46939 | |
| TPRHATIVTRESSEL | 121 | Q8WZA2 | |
| HSRSPARQESSRTSS | 1821 | Q9UQ35 | |
| ETRTHTLTRVNLESP | 186 | O15240 | |
| DHPIISTTDNLERSS | 36 | Q16650 | |
| ARHTSPSVISDLFTD | 46 | Q8WXH0 | |
| IVTDSNSRVSEPHRS | 836 | Q68EM7 | |
| HTISDLSRSSRGELI | 376 | P10244 | |
| RDAHRTVTETSLLSE | 1921 | P25391 | |
| SEPSARHVDSLSQRS | 71 | Q9UHD8 | |
| GEESSRSSTAVRRHP | 381 | Q9Y252 | |
| RSSTAVRRHPTITLD | 386 | Q9Y252 | |
| ETEEDTSSSPHRIRS | 61 | P0DJ93 | |
| RHTLAEVSTRLSPLT | 471 | A0A0B4J2F2 | |
| RHTLAEVSTRLSPLT | 471 | P57059 | |
| SSPEALRQSREHLLS | 416 | A6NL88 | |
| AEIRAPSADTARSHI | 96 | Q9BUA3 | |
| LSSRSSLSRHHPEES | 216 | Q8IX21 | |
| ALTSDSSRELTPHSA | 1021 | A1L4H1 | |
| SSRELTPHSALTSEA | 1026 | A1L4H1 | |
| RSEPETRETARSTHV | 276 | E7EW31 | |
| PHRITQRDTSRASST | 281 | Q9H2D6 | |
| RALVADSHPESERIS | 1656 | Q01082 | |
| ITSSPVAHLASRSRV | 686 | Q8WYL5 | |
| PSQIHSEDTLTLRTS | 161 | Q8TBZ0 | |
| SVPRSRVHLSRSSSQ | 996 | Q0VD83 | |
| DSAAISPEHRRQSTL | 796 | Q8WXI2 | |
| SVRSETDASLHRLVA | 511 | Q9BXU1 | |
| DTSLRESLHPVTRSL | 121 | Q8ND24 | |
| INSLHTSPRLARTET | 316 | Q8WYP3 | |
| ISARFPHRSADVTTS | 281 | Q92574 | |
| VSSLPRSQRDDLSLH | 91 | Q9NUR3 | |
| TFNRRIPTEHSVLES | 261 | Q86W11 | |
| ELPRIHKATSSSRSE | 3011 | O60673 | |
| RLTLPHSIRSDSEDI | 81 | O76021 | |
| PNRVASSRISDTHLA | 111 | Q5JUX0 | |
| LSEATRGTDELHSPS | 141 | Q96A56 | |
| EESSPSHDRSRTVSA | 481 | P78362 | |
| TAAHATDSALSRPTL | 306 | Q9H0E3 | |
| AQSRDVTTRITLPSH | 336 | Q9H0E3 | |
| PDRSCTERHVSSSDR | 526 | Q9NUY8 | |
| TPFSRLTVDSHLSRS | 1021 | Q6IQ55 | |
| TLIRSFQPHEDRISS | 466 | Q8IV35 | |
| TTQITHRPRVSRASS | 181 | O60667 | |
| TESAAELARRHSIPT | 46 | A8MPS7 | |
| RSRSSHARPVSLATS | 21 | Q86V25 | |
| GEVASSLSSTEIRRH | 436 | Q9BZ95 | |
| SESTVSRIRTEHFPL | 81 | P0DTU4 | |
| SRIRTEHFPLTLESA | 86 | P0DTU4 | |
| SVSPSESLRASEKHR | 201 | Q04726 | |
| PRSSAATHSLETQEL | 71 | Q8TCN5 | |
| THPTQRLVVTSSRDT | 331 | Q9Y2I8 | |
| SESTVSRIRTEHFPL | 81 | A0A075B6N4 | |
| SRIRTEHFPLTLESA | 86 | A0A075B6N4 | |
| RSTIARHLLSDQTDP | 1016 | Q14139 | |
| SAVRTSVPLHRSRDE | 106 | Q6ZMP0 | |
| QSEPRISESLVRHAS | 1746 | Q5T4S7 | |
| AHLDPQLRTRLTSDS | 281 | P11498 | |
| DSETRTHSIIPRGSL | 206 | Q9Y4A5 | |
| ETLSHLSDTTVRLSP | 536 | Q6P2D8 | |
| QESRSLSPSHLTEDR | 871 | Q5T200 | |
| RSHERTDPINTLSVE | 821 | Q9Y2L8 | |
| RHSEAADSPRSSTVH | 901 | Q9UNY4 | |
| VTPSRHRNSSSESAI | 2426 | Q5THJ4 | |
| TTSVRREEPTTFHSR | 3961 | Q9UKN1 | |
| RGSIRRISLDTSDHT | 1361 | O75096 | |
| SECSSVHTAATPERR | 1871 | O75096 | |
| SSGERTTLRSASPHR | 6 | Q9ULJ8 |